Association of CSF GAP-43 and APOE ε4 with Cognition in Mild Cognitive Impairment and Alzheimer's Disease

被引:7
|
作者
Zhu, Yueli [1 ]
Guo, Xiaoming [2 ]
Zhu, Feng [1 ]
Zhang, Qin [1 ,3 ]
Yang, Yunmei [1 ,3 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Geriatr, Hangzhou 310003, Peoples R China
[2] Tongde Hosp Zhejiang Prov, Dept Neurosurg, Hangzhou 310012, Peoples R China
[3] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Key Lab Diag & Treatment Aging & Phys Chem Injury, Hangzhou 310003, Peoples R China
基金
中国国家自然科学基金;
关键词
Alzheimer's disease; growth-associated protein 43; Apolipoprotein E epsilon 4; synaptic loss; biomarker; AMYLOID-BETA; SYNAPSE LOSS; PROTEIN; TAU; NEUROGRANIN; GENOTYPE; CA1;
D O I
10.3390/cells12010013
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The growth-associated protein 43 (GAP-43) is a presynaptic phosphoprotein in cerebrospinal fluid (CSF). The epsilon 4 allele of apolipoprotein E (APOE) is an important genetic risk factor for Alzheimer's disease (AD). We aimed to evaluate the association of CSF GAP-43 with cognition and whether this correlation was related to the APOE epsilon 4 status. We recruited participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database, and they were divided into cognitively normal (CN) epsilon 4 negative (CN epsilon 4-), CN epsilon 4 positive (CN epsilon 4+), mild cognitive impairment (MCI) epsilon 4 negative (MCI epsilon 4-), MCI epsilon 4 positive (MCI epsilon 4+), AD epsilon 4 negative (AD epsilon 4-), and AD epsilon 4 positive (AD epsilon 4+) groups. Spearman's correlation was utilized to evaluate the relationship between CSF GAP-43 and core AD biomarkers at the baseline. We performed receiver-operating characteristic (ROC) curve analyses to investigate the diagnostic accuracy of CSF GAP-43. The correlations between CSF GAP-43 and the Mini-Mental State Examination (MMSE) scores and brain atrophy at baseline were assessed by using multiple linear regression, while the association between CSF GAP-43 and MMSE scores at the follow-up was tested by performing the generalized estimating equation (GEE). The role of CSF GAP-43 in the conversion from MCI to AD was evaluated using the Cox proportional hazard model. We found that the CSF GAP-43 level was significantly increased in MCI epsilon 4+, AD epsilon 4- and AD epsilon 4+ groups compared with CN epsilon 4- or MCI epsilon 4- group. The negative associations between the CSF GAP-43 and MMSE scores at the baseline and follow-up were found in MCI epsilon 4- and MCI epsilon 4+ groups. In addition, baseline CSF GAP-43 was able to predict the clinical progression from MCI to AD. CSF GAP-43 may be a promising biomarker to screen cognition for AD. The effects of CSF GAP-43 on cognition were suspected to be relevant to APOE epsilon 4 status.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Association of hemoglobin levels and cognitive function in Alzheimer's disease and mild cognitive impairment
    Kim, H.
    Lee, K. J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S1029 - S1029
  • [32] Quantifying cognition and behavior in normal aging, mild cognitive impairment, and Alzheimer's disease
    Giraldo, Diana L.
    Sijbers, Jan
    Romero, Eduardo
    13TH INTERNATIONAL CONFERENCE ON MEDICAL INFORMATION PROCESSING AND ANALYSIS, 2017, 10572
  • [33] APOE-Dependent Phenotypes in Subjects with Mild Cognitive Impairment Converting to Alzheimer's Disease
    Morgen, Katrin
    Froelich, Lutz
    Tost, Heike
    Plichta, Michael M.
    Koelsch, Heike
    Rakebrandt, Fabian
    Rienhoff, Otto
    Jessen, Frank
    Peters, Oliver
    Jahn, Holger
    Luckhaus, Christian
    Huell, Michael
    Gertz, Hermann-Josef
    Schroeder, Johannes
    Hampel, Harald
    Teipel, Stefan J.
    Pantel, Johannes
    Heuser, Isabella
    Wiltfang, Jens
    Ruether, Eckart
    Kornhuber, Johannes
    Maier, Wolfgang
    Meyer-Lindenberg, Andreas
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 37 (02) : 389 - 401
  • [34] ACE activity in CSF of patients with mild cognitive impairment and Alzheimer disease
    He, M.
    Ohrui, T.
    Maruyama, M.
    Tomita, N.
    Nakayama, K.
    Higuchi, M.
    Furukawa, K.
    Arai, H.
    NEUROLOGY, 2006, 67 (07) : 1309 - 1310
  • [35] CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
    Mattsson, Niklas
    Zetterberg, Henrik
    Hansson, Oskar
    Andreasen, Niels
    Parnetti, Lucilla
    Jonsson, Michael
    Herukka, Sanna-Kaisa
    van der Flier, Wiesje M.
    Blankenstein, Marinus A.
    Ewers, Michael
    Rich, Kenneth
    Kaiser, Elmar
    Verbeek, Marcel
    Tsolaki, Magda
    Mulugeta, Ezra
    Rosen, Erik
    Aarsland, Dag
    Visser, Pieter Jelle
    Schroeder, Johannes
    Marcusson, Jan
    de Leon, Mony
    Hampel, Harald
    Scheltens, Philip
    Pirttilae, Tuula
    Wallin, Anders
    Jonhagen, Maria Eriksdotter
    Minthon, Lennart
    Winblad, Bengt
    Blennow, Kaj
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (04): : 385 - 393
  • [36] Gap-43 message levels in anterior cerebellum in Alzheimer's disease
    Cheetham, JE
    Martzen, MR
    Kazee, AM
    Coleman, PD
    MOLECULAR BRAIN RESEARCH, 1996, 36 (01): : 145 - 151
  • [37] Association of ankle brachial index among the elderly with normal cognition, amnestic mild cognitive impairment and Alzheimer's disease
    Kim, Shin-Gyeom
    Lee, Dong-Young
    Seo, Eun Hyun
    Shon, Jae Min
    Sohn, Bo Kyung
    Woo, Jong Inn
    Kim, Jee Wook
    Park, Shin Young
    Yoon, Jong Choul
    Jhoo, Jin Hyeong
    INTERNATIONAL PSYCHOGERIATRICS, 2013, 25 : S112 - S112
  • [38] Association of ankle brachial index among the elderly with normal cognition, amnestic mild cognitive impairment and Alzheimer's disease
    Jung, H.
    Kim, S.
    Lee, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S634 - S634
  • [39] Inflammation in mild cognitive impairment and mild Alzheimer's disease
    Santana, I
    Guerreiro, R
    Paiva, A
    Sarmento, A
    Santiago, B
    Barbosa, V
    Oliveira, C
    NEUROBIOLOGY OF AGING, 2004, 25 : S534 - S534
  • [40] Is mild cognitive impairment bridging the gap between normal aging and Alzheimer's disease?
    Smith, G
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 2002, (62): : 97 - 104